Umbilical and systemic responses to angiotensin II differ in term fetal sheep, and peripheral vascular responses are attenuated or absent before and after birth. These observations may reflect developmental differences in angiotensin II receptor (AT) subtypes in vascular smooth muscle (VSM). Studies of AT subtype ontogeny and regulation are generally limited to the aorta, which may not be extrapolated to other arteries, and neither is completely described during ovine development. We therefore characterized VSM AT subtype expression and regulation throughout an extended period of development in umbilical and carotid artery and aorta from fetal (85-146 d gestation), postnatal (5-23 d), and adult sheep, measuring AT 1 and AT 2 mRNA and protein and performing immunohistochemistry. Parallel increases in umbilical AT 1 mRNA and protein began early in gestation and continued to term, and although AT 2 mRNA was unchanged, protein levels decreased Ͼ90% at term. Fetal carotid AT 1 mRNA was Ͻ40% of adult values and unchanged before birth; however, AT 1 protein rose Ͼ2-fold at term. After birth, AT 1 mRNA increased to 85% of adult values and was associated with another 2-fold rise in protein. In contrast, carotid AT 2 mRNA and protein fell in parallel throughout development and were barely detectable in the newborn and the adult. Immunostaining was consistent with observations in both arteries. A third pattern occurred in aortic VSM. The ontogeny of AT subtype expression and regulation is vessel specific, with changes in umbilical VSM beginning very early in development. Although the mechanisms that regulate mRNA and protein expression are unclear, these changes parallel differences in VSM maturation and function and local blood flow. The renin-angiotensin system (RAS) is expressed early in gestation and considered an important modulator of cardiovascular development, adaptation, and blood pressure control before and after birth (1-4). In fetal and neonatal sheep, hemorrhage and hypovolemia increase circulating angiotensin II (Ang II) (5-7). Although inhibition of Ang II receptors (AT) or converting enzyme accentuates hypovolemic episodes (3,7), their effects on basal arterial pressure are inconsistent (8,9). AT blockade also modifies the baroreflex and reflex control of renal sympathetic nerve activity after birth (10,11). Recent evidence suggests the RAS also contributes to the differentiation, maturation, and/or growth of vascular smooth muscle (VSM) (12-15). Thus, prevailing evidence suggests the RAS contributes to the regulation of vascular function, maturation, and growth during development.The effects of the RAS are mediated primarily by Ang II activation of ATs, which belong to the superfamily of seven transmembrane receptors (12,16,17). They are present in mammalian fetal and adult VSM and demonstrate similar binding characteristics during development and in the adult (18 -20). In fetal sheep, AT binding density and affinity in aorta and placental arteries are unchanged in the last third of gestation and resemble ...